Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) EBT Margin: 2017-2018

Historic EBT Margin for Astria Therapeutics (ATXS) over the last 2 years, with Sep 2018 value amounting to 58,410.00%.

  • Astria Therapeutics' EBT Margin rose 6121480.00% to 58,410.00% in Q3 2018 from the same period last year, while for Sep 2018 it was -17,118.00%, marking a year-over-year change of. This contributed to the annual value of 26,046.00% for FY2018, which is 3152520.00% up from last year.
  • As of Q3 2018, Astria Therapeutics' EBT Margin stood at 58,410.00%, which was up 190.90% from 20,078.79% recorded in Q2 2018.
  • In the past 5 years, Astria Therapeutics' EBT Margin registered a high of 58,410.00% during Q3 2018, and its lowest value of -2,804.80% during Q3 2017.
  • Its 2-year average for EBT Margin is 13,958.16%, with a median of 5,513.39% in 2017.
  • Data for Astria Therapeutics' EBT Margin shows a peak YoY soared of 6,121,480bps (in 2018) over the last 5 years.
  • Quarterly analysis of 2 years shows Astria Therapeutics' EBT Margin stood at -2,218.40% in 2017, then spiked by 6,121,480bps to 58,410.00% in 2018.
  • Its EBT Margin was 58,410.00% in Q3 2018, compared to 20,078.79% in Q2 2018 and 13,445.61% in Q1 2018.